The clinic on the corner looks exactly the same. Same sign, same receptionist, same smell of antiseptic and dog treats. But the name on the deed changed two years ago, and your bill has been climbing ever since. The dental cleaning that cost $300 now costs $600. The wellness exam comes with a $180 blood panel you did not ask for. Nobody told you the practice was acquired. Nobody had to.
Over the past decade, private equity firms and giant corporations have quietly bought up a staggering share of American veterinary practices — and researchers tie that buying spree directly to steeper prices. PBS NewsHour reports that U.S. veterinary costs have risen roughly 60 percent since 2014, far outpacing overall inflation. The frustrating part, as one consumer advocate put it: the clinic usually looks exactly the same.
A decade ago, corporate ownership of veterinary clinics sat at roughly 10 percent or less. Today, estimates put corporate and private equity ownership at 30 to 50 percent of U.S. general practices — and in specialty and emergency care, including oncology and cardiology, PBS puts corporate ownership as high as 75 percent. The U.S. veterinary services market reached $36.52 billion in 2024, projected to hit $68.67 billion by 2033, per Grand View Research. That growth is the prize, and the buyers have been relentless.
The single largest owner is not a private equity firm. It is Mars Inc. — the candy company. Mars owns roughly 2,500 to 3,000 clinics globally under the Banfield, VCA, and BluePearl names, making it the largest veterinary operator on earth. The Skittles conglomerate is also, by some measures, the largest provider of pet healthcare in America.
The private equity roster is a who’s-who of the industry’s biggest names. JAB Consumer Partners — the German conglomerate behind Krispy Kreme and Panera — built a vet empire through National Veterinary Associates before selling NVA to Ethos Veterinary Health in July 2025. KKR backs PetVet Care Centers, which completed a $2.3 billion unitranche recap in 2023. TSG Consumer Partners owns Thrive Pet Healthcare. Shore Capital, Harvest Partners, Cressey & Company, and Southern Veterinary Partners all run active platforms. Acquisition multiples tell you how coveted the assets are: 5x to 7x EBITDA for small practices, 8x to 11.5x for $1M–$3M EBITDA practices, and 11x to 13x-plus for platform-eligible operators above $3M EBITDA, per CT Acquisitions’ 2026 consolidation report.
The mechanism is not mysterious. Corporate management implements revenue discipline that independent practices never systematically applied: standardized pricing for routine procedures, production quotas for veterinarians, and protocols that route every wellness exam through high-margin diagnostic panels and prescription diet recommendations.
The impact on the consumer wallet is immediate. A routine dental cleaning or minor surgical procedure that cost $300 at an independent clinic can easily double following a corporate acquisition. Because the acquiring firm often controls dozens of clinics within a single metropolitan radius, it holds localized pricing power — the consumer’s ability to shop for a second opinion erodes as the independents disappear.
The data backs the anecdote. The UK’s Competition and Markets Authority investigated the same phenomenon in Britain and found pet owners paying roughly 16% more at corporate-owned vets versus independents — attributing an extra £1 billion in spending over five years to corporate ownership. In the U.S., Bloomberg, citing the nonprofit CATalyst Council, reported veterinary service prices rising at roughly twice the overall inflation rate. A Gallup poll found more than half of Americans had postponed recommended pet care, with cost the primary reason cited.
The corporatization has a second-order effect: a staffing crisis. Veterinarians and technicians report record burnout, citing pressure to maximize daily patient volume and prioritize throughput over care. The exodus worsens appointment shortages, which further reduces competitive pressure on prices. It is a loop, and it runs in one direction.
The private equity defense deserves a hearing, because parts of it are true. Independent veterinary practice was, in many markets, an economically fragile business — thin margins, no capital for equipment upgrades, no leverage with suppliers. Corporate ownership brought professional management, better diagnostic equipment, standardized protocols, and in some cases genuinely better medicine. A corporate-owned specialty hospital with a $2 million MRI machine offers care the independent down the street cannot.
Scale also funds things independents cannot: 24-hour emergency coverage, specialist networks, structured training programs. And the multiples — 11x to 13x EBITDA — reflect real value creation, not just financial engineering. Well-run platforms genuinely improve operations.
But the defense has a hole the industry cannot patch: the FTC has begun forcing divestitures. Federal regulators required major veterinary networks to sell off emergency hospitals in crowded urban markets on explicit antitrust grounds — an official finding that consolidation had gone far enough to harm competition. When the antitrust cops start breaking up your roll-up, the “we’re just professionalizing the industry” narrative gets harder to sustain.
First, know who owns your clinic. Ask directly — practices are not required to disclose it, but most will answer. Corporate-owned is not automatically bad, but it is information that should factor into price comparisons.
Second, get the itemized estimate before authorizing treatment, and question the add-ons. The $180 wellness panel on a healthy two-year-old dog is where margin lives. Ask what is medically necessary versus recommended, and what happens if you decline.
Third, price-shop the big-ticket procedures. The price dispersion in veterinary care is enormous — the same surgery can cost double at the corporate specialty hospital versus the independent across town. For non-emergency procedures, the phone calls are worth it.
Fourth, consider pet insurance before you need it — but read the exclusions. Premiums are rising fast (one reporter’s premium jumped 30% year over year on a healthy young dog), and preexisting-condition exclusions can gut the value. The employer-benefits channel — pet insurance through workplace enrollment at Google, Amazon, Microsoft — is emerging as the most price-competitive distribution, per industry analysis.
The deeper question is whether the consolidation wave has crested. The FTC’s intervention, the UK’s billion-pound finding, and multiples that leave little room for further arbitrage all suggest the easy roll-up phase is ending. What remains is the pricing structure it built — and pet owners will be paying it for years.
The definitive source for veterinary pricing intelligence is still up for grabs. VeterinaryPricing.com is available for acquisition by the company that will own this category — inquiries to info@primedomaincapital.com.
Fixed price. Clean transfer through Escrow.com. Confidential inquiry.
Spay/neuter, dental cleaning, TPLO surgery, emergency care — the real 2026 price ranges for twenty common procedures, and the three variables that make the ranges so wide.
Read →
Two quotes for the same knee surgery, $2,400 apart. How consolidation, cost structures, and an opacity gap turned veterinary pricing into the wild west of consumer markets.
Read →